These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7683485)

  • 21. The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia.
    Tricot G; Boogaerts MA; Vlietinck R; Emonds MP; Verwilghen RL
    Br J Haematol; 1987 May; 66(1):37-44. PubMed ID: 3474014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases.
    Frassoni F; Barrett AJ; Grañena A; Ernst P; Garthon G; Kolb HJ; Prentice HG; Vernant JP; Zwaan FE; Gratwohl A
    Br J Haematol; 1988 Nov; 70(3):317-20. PubMed ID: 3061443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia.
    Miggiano MC; Gherlinzoni F; Rosti G; Bandini G; Visani G; Fiacchini M; Ricci P; Testoni N; Motta MR; Geromin A; Rizzi S; Belardinelli A; Mangianti S; Manfroi S; Tura S
    Leukemia; 1996 Mar; 10(3):402-9. PubMed ID: 8642854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors.
    Schiller G; Feig SA; Territo M; Wolin M; Lill M; Belin T; Hunt L; Nimer S; Champlin R; Gajewski J
    Br J Haematol; 1994 Sep; 88(1):72-8. PubMed ID: 7803259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.
    Frassoni F; Labopin M; Powles R; Mary JY; Arcese W; Bacigalupo A; Bunjes D; Gluckman E; Ruutu T; Schaefer UW; Sierra J; Vernant JP; Willemze R; de Witte T; Gorin NC
    Lancet; 2000 Apr; 355(9213):1393-8. PubMed ID: 10791522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.
    Versluis J; Hazenberg CL; Passweg JR; van Putten WL; Maertens J; Biemond BJ; Theobald M; Graux C; Kuball J; Schouten HC; Pabst T; Löwenberg B; Ossenkoppele G; Vellenga E; Cornelissen JJ;
    Lancet Haematol; 2015 Oct; 2(10):e427-36. PubMed ID: 26686044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparison.
    Anderson CC; Goldstone AH; Linch DC; Jones HM; Franklin IM; Boughton BJ; Cawley JC; Richards JD
    Bone Marrow Transplant; 1987 Feb; 1(3):271-9. PubMed ID: 3332138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
    Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS
    J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
    Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
    Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
    Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
    J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia.
    De La Serna J; Francisco Tomás J; Solano C; García de Paredes ML; Campbell J; Grande C; Diaz-Mediavilla J
    Leuk Lymphoma; 1997 Apr; 25(3-4):365-72. PubMed ID: 9168446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of acute myeloid leukaemia--5 years experience at Armed Forces Bone Marrow Transplant Centre, Rawalpindi.
    Ullah K; Ahmed P; Raza S; Satti TM; Chaudhry QU; Akhtar F; Kamal MK; Akhtar FM; Khan B
    J Pak Med Assoc; 2007 Sep; 57(9):434-9. PubMed ID: 18072636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous bone marrow transplantation in relapsed adult acute leukemia.
    Dicke KA; Zander AR; Spitzer G; Verma DS; Peters LJ; Vellekoop L; Thomson S; Stewart D; Hester JP; McCredie KB
    Exp Hematol; 1979; 7 Suppl 5():170-87. PubMed ID: 400685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
    Rees JK; Gray RG; Swirsky D; Hayhoe FG
    Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study.
    Thalhammer F; Geissler K; Jäger U; Kyrle PA; Pabinger I; Mitterbauer M; Gisslinger H; Knöbl P; Laczika K; Schneider B; Haas OA; Lechner K
    Ann Hematol; 1996 Apr; 72(4):216-22. PubMed ID: 8624375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation.
    Parovichnikova EN; Loukianova IA; Troitskaya VV; Drokov MY; Lobaova TI; Kuzmina LA; Sokolov AN; Kokhno AV; Fidarova ZT; Baskhaeva GA; Gavrilina OA; Vasilyeva VA; Obukhova TN; Kuznetsova SA; Sudarikov AB; Dvirnik VN; Galtseva IV; Davidiva JO; Kulikov SM; Savchenko VG
    Ter Arkh; 2018 Aug; 90(7):14-22. PubMed ID: 30701918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
    Griffin PT; Komrokji RS; Sweet K; Al Ali NH; Padron E; Kubal TE; List AF; Lancet JE
    Am J Hematol; 2017 Mar; 92(3):232-237. PubMed ID: 28006850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
    Shaw PJ; Bergin ME; Burgess MA; Dalla Pozza L; Kellie SJ; Rowell G; Stevens MM; Webster BH; Bradstock KF
    J Clin Oncol; 1994 Oct; 12(10):2138-45. PubMed ID: 7931485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine.
    Dalley CD; Lillington DL; Bradburn M; Carter M; Amess JA; Rohatiner AZ; Lister TA
    Hematol J; 2002; 3(5):237-43. PubMed ID: 12391541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remission.
    Herve P; Rozenbaum A; Plouvier E; Flesch M; Cahn JY; Farradji A; Bergerat JP; Adjizian JC; Pignon B
    Cancer Treat Rep; 1982 Nov; 66(11):1983-5. PubMed ID: 6754076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.